Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|AREN1921||COG||Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)||Pediatric CIRB||Available to Open|
|AREN0533||COG||Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors: A Groupwide Phase III Study||Pediatric CIRB||Available to Open|
|AALL0932||COG||Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)||Pediatric CIRB||Available to Open|
|GOG-0201||GOG||Treatment of Patients with Stage IB2 Carcinoma of the Cervix: A Randomized Comparison of Radical Hysterectomy and Tailored Chemoradiation VERSUS Primary Chemoradiation||Adult CIRB - Late Phase Emphasis||Completed|
|AGCT0521||COG||Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors with Paclitaxel; Ifosfamide and Carboplatin: A Groupwide Phase II Study||Pediatric CIRB||Completed|
|URCC-16070||NCORP-University of Rochester Cancer Center||Treatment of Refractory Nausea||Cancer Prevention and Control CIRB||Available to Open|
|ARET0331||COG||Trial of Systemic Neoadjuvant Chemotherapy for Group B Intraocular Retinoblastoma: A Phase III Limited Institution Study||Pediatric CIRB||Completed|
|ALTE05N1||COG||Umbrella Long-Term Follow-Up Protocol||Pediatric CIRB||Available to Open|
|WF-97415||NCORP-Wake Forest University||Understanding and Predicting Breast Cancer Events after Treatment (UPBEAT)||Cancer Prevention and Control CIRB||Available to Open|
|AALL03N1||COG||Understanding the Ethnic and Racial Differences in Survival in Children with Acute Lymphoblastic Leukemia||Pediatric CIRB||Available to Open|